Stocksigma LogoStocksigma Logo

Aarey Drugs & Pharmaceuticals Reports Preferential Issue Fund Utilization

Aarey Drugs & Pharmaceuticals reported zero deviation in the utilization of proceeds from its preferential convertible warrants issue for the quarter ended

Aarey Drugs & Pharmaceuticals Reports Preferential Issue Fund Utilization

Aarey Drugs & Pharmaceuticals Ltd · Others (Uncategorized) · 15 Nov 2026, 12:30 am

Aarey Drugs & Pharmaceuticals Reports Preferential Issue Fund Utilization Aarey Drugs & Pharmaceuticals reported zero deviation in the utilization of proceeds from its preferential convertible warrants issue for the quarter ended 30th Sep'26. Out of the total ₹3,190.00 Lakhs issue size (50,00,000 warrants at ₹63.80 each), the company received ₹2,481.82 Lakhs up to 30th Sep'26, which includes ₹797.50 Lakhs upon allotment on 23rd May'25 and ₹1,684.32 Lakhs from converting 35,20,000 warrants during the quarter. To date, ₹2,081.82 Lakhs has been deployed toward stated corporate objectives, with ₹400.00 Lakhs remaining unutilized in bank accounts.

Original exchange filing (PDF)

More announcements from Aarey Drugs & Pharmaceuticals Ltd

All Aarey Drugs & Pharmaceuticals Ltd announcements